|
|
| 5-Day | 1,866 |
| 10-Day | 1,643 |
| 30-Day | 1,837 |
| 5-Day | 1,866 |
| 10-Day | 1,643 |
| 30-Day | 1,837 |
| 5-Day | 281 |
| 10-Day | 462 |
| 30-Day | 990 |
| 5-Day | 281 |
| 10-Day | 462 |
| 30-Day | 990 |
52 Week Low
Bal Pharma has hit 52wk low of Rs 16.00 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 16.25 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.50 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 16.00 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.75 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.50 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.55 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.25 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 16.05 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.70 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 16.00 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 15.65 on NSE52 Week Low
Bal Pharma has hit 52wk low of Rs 16.40 on NSEOnly Buyers
Only Buyers in Bal Pharma on BSE
| Days | BSE | NSE |
| 30 | 21.32 | 20.74 |
| 50 | 19.66 | 18.91 |
| 150 | 17.41 | 18.05 |
| 200 | 0.00 | 0.00 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Bal Pharma
| Consolidated | (Jun '11) Quarterly |
(Mar '11) Yearly |
| Net Sales | 28.97 | 116.88 |
| Other Income | 0.11 | 0.50 |
| PBDIT | 2.46 | 9.80 |
| Net Profit | 0.13 | 0.40 |
| Total Share Capital | 10.57 |
| Net Worth | 44.62 |
| Total Debt | 46.03 |
| Net Block | 51.83 |
| Investments | 0.02 |
| Net Current Assets | 37.93 |
| Total Assets | 90.65 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 583.95 | -0.56 | 650.00 | 357.50 | 120,945.62 |
| Dr Reddys Labs | 2443.70 | -0.29 | 2545.00 | 1764.00 | 41,567.27 |
| Lupin | 875.45 | 0.34 | 946.35 | 598.00 | 39,235.74 |
| Cipla | 387.50 | -0.13 | 450.00 | 370.95 | 31,113.20 |
| GlaxoSmithKline | 2462.95 | -1.08 | 2899.00 | 2005.00 | 20,861.93 |
| More » | |||||
| Sep' 13 | Jun' 13 | Mar' 13 | Dec' 12 | |
| Promoter | 51.37 | 51.37 | 51.37 | 51.37 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 |
| Others | 48.61 | 48.61 | 48.61 | 48.61 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| No Mutual Funds Holding the share |
Bal Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 22.20 crore.The company has reported a consolidated sales of Rs 28.97 crore and a Net Profit of Rs 0.13 crore for the quarter ended Jun 2011.
The company management includes Shailesh Siroya - Managing Director, S Prasanna - Whole Time Director, Shrenik Siroya - Non Executive Director, G S R Subba Rao - Independent Director, S Pramod Kumar - Independent Director, Ajit Kumar - Nominee Director.
It is listed on the BSE with a BSE Code of 524824 and the NSE with an NSE Code of BALPHARMA.
Its Registered office is at 21 & 22, Bommasandra Industrial Area,,Hosur Road Bangalore,Karnataka - 560099.
Their Registrars are TSR Darashaw Ltd.
SET SMS ALERT